Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Gary L. Pattee, Angela Genge, Philippe Couratier, Christian Lunetta, Gen Sobue, Masashi Aoki, Hiide Yoshino, Carlayne E. Jackson, James Wymer, Alejandro Salah & Sally Nelson. (2023) Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis. Expert Review of Neurotherapeutics 0:0, pages 1-8.
Read now
Read now
Christina N. Fournier, Virginia James & Jonathan D. Glass. (2023) Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-R. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 311-316.
Read now
Read now
Danielle Boyce, Michael Robinson, Jesse M. Cedarbaum, Lisa M. Shank, Christopher J. McDermott & Ruben P. A. van Eijk. (2023) A qualitative evaluation of the revised amyotrophic lateral sclerosis functional rating scale (ALSFRS-R) by the patient community: a web-based cross-sectional survey. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 272-280.
Read now
Read now
Jeremy M. Shefner, Jinsy A. Andrews, Angela Genge, Carlayne Jackson, Noah Lechtzin, Timothy M. Miller, Bettina M. Cockroft, Lisa Meng, Jenny Wei, Andrew A. Wolff, Fady I. Malik, Cynthia Bodkin, Benjamin R. Brooks, James Caress, Annie Dionne, Dominic Fee, Stephen A. Goutman, Namita A. Goyal, Orla Hardiman, Ghazala Hayat, Terry Heiman-Patterson, Daragh Heitzman, Robert D. Henderson, Wendy Johnston, Chafic Karam, Matthew C. Kiernan, Stephen J. Kolb, Lawrence Korngut, Shafeeq Ladha, Genevieve Matte, Jesus S. Mora, Merrilee Needham, Bjorn Oskarsson, Gary L. Pattee, Erik P. Pioro, Michael Pulley, Dianna Quan, Kourosh Rezania, Kerri L. Schellenberg, David Schultz, Christen Shoesmith, Zachary Simmons, Jeffrey Statland, Shumaila Sultan, Andrea Swenson, Leonard H. Van Den Berg, Tuan Vu, Steve Vucic, Michael Weiss, Ashley Whyte-Rayson, James Wymer, Lorne Zinman & Stacy A. Rudnicki. (2021) A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 287-299.
Read now
Read now
. (2020) ALSUntangled 56: “ten red flags”-things to be wary of in alternative or off-label products. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 642-647.
Read now
Read now
Jesus S. Mora, Angela Genge, Adriano Chio, Conrado J. Estol, Delia Chaverri, Maria Hernández, Saúl Marín, Javier Mascias, Gabriel E. Rodriguez, Monica Povedano, Andrés Paipa, Raul Dominguez, Josep Gamez, Maria Salvado, Christian Lunetta, Carlos Ballario, Nilo Riva, Jessica Mandrioli, Alain Moussy, Jean-Pierre Kinet, Christian Auclair, Patrice Dubreuil, Vincent Arnold, Colin D. Mansfield & Olivier Hermine. (2020) Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 5-14.
Read now
Read now
JosÉ E. de la Rubia, Eraci Drehmer, JosÉ L. Platero, MarÍa Benlloch, Jordi Caplliure-Llopis, Carlos Villaron-Casales, Nieves de Bernardo, Jorge AlarcÓn, Cristian Fuente, Sandra Carrera, David Sancho, Pilar GarcÍa-Pardo, Raquel Pascual, Marta JuÁrez, María Cuerda-Ballester, Alfonso Forner, Sandra Sancho-Castillo, Carlos Barrios, Elena Obrador, Patricia Marchio, Rosario Salvador, Holly E. Holmes, Ryan W. Dellinger, Leonard Guarente & José M. Estrela. (2019) Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 115-122.
Read now
Read now
Carlayne Jackson, Mamede De Carvalho, Angela Genge, Terry Heiman-Patterson, Jeremy M. Shefner, Jenny Wei & Andrew A. Wolff. (2018) Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 506-512.
Read now
Read now
Iyas Daghlas, Teresa E. Lever & Emily Leary. (2018) A retrospective investigation of the relationship between baseline covariates and rate of ALSFRS-R decline in ALS clinical trials. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:3-4, pages 206-211.
Read now
Read now
Bello Hamidou, Benoit Marin, Geraldine Lautrette, Marie Nicol, William Camu, Philippe Corcia, Marie-Christine Arnes-Bes, Christine Tranchant, Pierre Clavelou, Didier Hannequin, Giroud Maurice, Katell Beauvais, Jean-Christophe Antoine, Véronique Danel-Brunaud, Fausto Viader, Pierre-Marie Preux & Philippe Couratier. (2017) Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment*. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 519-527.
Read now
Read now
Benoît Marin, Elisa Bianchi, Elisabetta Pupillo, Christian Lunetta, Lucio Tremolizzo, Giancarlo Logroscino, Adriano Chiò, Pierre Marie Preux & Ettore Beghi. (2016) Non-self-sufficiency as a primary outcome measure in ALS trials. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:1-2, pages 77-84.
Read now
Read now
Roberto Gomeni & Maurizio Fava. (2014) Amyotrophic lateral sclerosis disease progression model. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:1-2, pages 119-129.
Read now
Read now
. (2013) THEME 5 IMPROVING DIAGNOSIS, PROGNOSIS AND DISEASE PROGRESSION. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:sup2, pages 120-136.
Read now
Read now
Stacy A. Rudnicki, James D. Berry, Evan Ingersoll, Don Archibald, Merit E. Cudkowicz, Douglas A. Kerr & Yingwen Dong. (2013) Dexpramipexole effects on functional decline and survival in subjects with amyotrophic lateral sclerosis in a Phase II study: Subgroup analysis of demographic and clinical characteristics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:1, pages 44-51.
Read now
Read now
Articles from other publishers (53)
Flavia L. Lombardo, Stefania Spila Alegiani, Flavia Mayer, Marta Cipriani, Maria Lo Giudice, Albert Christian Ludolph, Christopher J. McDermott, Philippe Corcia, Philip Van Damme, Leonard H. Van den Berg, Orla Hardiman, Gabriele Nicolini, Nicola Vanacore, Brian Dickie, Alberto Albanese, Maria Puopolo, Paolo Tornese, Antoniangela Cocco, Michela Matteoli, Eliana Lauranzano, Maria Luisa Malosio, Chiara Adriana Elia, Adriano Chiò, Umberto Manera, Cristina Moglia, Andrea Calvo, Paolina Salamone, Giuseppe Fuda, Carlo Colosimo, Cristina Spera, Prabha Cristina Ranchicchio, Giuseppe Stipa, Domenico Frondizi, Christian Lunetta, Valeria Sansone, Claudia Tarlarini, Francesca Gerardi, Vincenzo Silani, Alberto Doretti, Eleonora Colombo, Gianluca Demirtzidis, Gioacchino Tedeschi, Francesca Trojsi, Carla Passaniti, Stefania Ballestrero, Johannes Dorst, Ulrike Weiland, Andrea Fromm, Maximilian Wiesenfarth, Katharina Kandler, Simon Witzel, Markus Otto, Joachim Schuster, Thomas Meyer, André Maier, Dagmar Kettemann, Susanne Petri, Lars Müschen, Camilla Wohnrade, Anastasia Sarikidi, Alma Osmanovic, Julian Grosskreutz, Annekathrin Rödiger, Robert Steinbach, Benjamin Ilse, Uta Smesny, Robert Untucht, René Günther, Maximilian Vidovic, Pamela Shaw, Alexis Collins, Helen Wollff, Theresa Walsh, Lee Tuddenham, Mbombe Kazoka, David White, Stacy Young, Benjamin Thompson, Daniel Madarshahian, Suresh K. Chhetri, Amina Chaouch, Carolyn A. Young, Heike Arndt, Coliver Hanemann, Thomas Lambert, Stephane Beltran, Philippe Couratier, Florence Esselin, William Camu, Elisa De La Cruz, Gwendal Lemasson, Pegah Masrori, Sinead Maguire, Liz Fogarty, Toyosi Atoyebi & Niamh Ní Obáin. (2023) A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial. Trials 24:1.
Crossref
Crossref
Eleanor Roberts. (2023) A Review of Oral Fixed-Dose Sodium Phenylbutyrate and Ursodoxicoltaurine in People with Amyotrophic Lateral Sclerosis. EMJ Neurology, pages 2-12.
Crossref
Crossref
Cara Donohue, Jennifer L. Chapin, Amber Anderson, Lauren DiBiase, Lauren Tabor Gray, James P. Wymer & Emily K. Plowman. (2023) Sensitivity and specificity of the Amyotrophic Lateral Sclerosis Functional Rating Scale—Revised to detect dysarthria in individuals with amyotrophic lateral sclerosis. Muscle & Nerve 68:3, pages 296-302.
Crossref
Crossref
Satoru Morimoto, Shinichi Takahashi, Daisuke Ito, Yugaku Daté, Kensuke Okada, Chris Kato, Shiho Nakamura, Fumiko Ozawa, Chai Muh Chyi, Ayumi Nishiyama, Naoki Suzuki, Koki Fujimori, Tosho Kondo, Masaki Takao, Miwa Hirai, Yasuaki Kabe, Makoto Suematsu, Masahiro Jinzaki, Masashi Aoki, Yuto Fujiki, Yasunori Sato, Norihiro Suzuki, Jin Nakahara & Hideyuki Okano. (2023) Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery. Cell Stem Cell 30:6, pages 766-780.e9.
Crossref
Crossref
Xi Chen, Jiawen Xu, Jingyan Guo, Ting Ye, Baocheng Zhao, Shiming Fang, Yan Chen & Yi Dong. (2023) A Predictive Model and Survival Analysis for Tube Feeding in ALS Patients: A Prospective Cohort Study in a Chinese ALS Clinic. Acta Neurologica Scandinavica 2023, pages 1-13.
Crossref
Crossref
Shotaro Haji, Koji Fujita, Ryosuke Oki, Yusuke Osaki, Ryosuke Miyamoto, Hiroyuki Morino, Seiichi Nagano, Naoki Atsuta, Yuki Kanazawa, Yuki Matsumoto, Atsuko Arisawa, Hisashi Kawai, Yasutaka Sato, Satoshi Sakaguchi, Kenta Yagi, Tatsuto Hamatani, Tatsuo Kagimura, Hiroaki Yanagawa, Hideki Mochizuki, Manabu Doyu, Gen Sobue, Masafumi Harada & Yuishin Izumi. (2023) An Exploratory Trial of EPI-589 in Amyotrophic Lateral Sclerosis (EPIC-ALS): Protocol for a Multicenter, Open-Labeled, 24-Week, Single-Group Study. JMIR Research Protocols 12, pages e42032.
Crossref
Crossref
Susan L. Hartmaier, Thomas Rhodes, Suzanne F. Cook, Courtney Schlusser, Chao Chen, Steve Han, Neta Zach, Venkatesha Murthy & Shreya Davé. (2022) Qualitative measures that assess functional disability and quality of life in ALS. Health and Quality of Life Outcomes 20:1.
Crossref
Crossref
Fumihiro Takahashi, Osamu Kano, Yoshito Nagano, Takatomo Yoneoka, Sally Nelson & Yoshiteru Ushirogawa. (2022)
Associations between urate levels and amyotrophic lateral sclerosis functional score with edaravone treatment: Post hoc analysis of studies
MCI186
‐16,
MCI186
‐17, and
MCI186
‐19
. Muscle & Nerve 66:5, pages 583-592.
Crossref
Crossref
Alberto Albanese, Albert Christian Ludolph, Christopher J. McDermott, Philippe Corcia, Philip Van Damme, Leonard H. Van den Berg, Orla Hardiman, Gilberto Rinaldi, Nicola Vanacore & Brian Dickie. (2022) Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol. Frontiers in Neurology 13.
Crossref
Crossref
Christina N. Fournier. (2022) Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design. Neurotherapeutics 19:4, pages 1180-1192.
Crossref
Crossref
Ryosuke Oki, Yuishin Izumi, Koji Fujita, Ryosuke Miyamoto, Hiroyuki Nodera, Yasutaka Sato, Satoshi Sakaguchi, Hiroshi Nokihara, Kazuaki Kanai, Taiji Tsunemi, Nobutaka Hattori, Yuki Hatanaka, Masahiro Sonoo, Naoki Atsuta, Gen Sobue, Toshio Shimizu, Kazumoto Shibuya, Ken Ikeda, Osamu Kano, Kazuto Nishinaka, Yasuhiro Kojima, Masaya Oda, Kiyonobu Komai, Hitoshi Kikuchi, Nobuo Kohara, Makoto Urushitani, Yoshiaki Nakayama, Hidefumi Ito, Makiko Nagai, Kazutoshi Nishiyama, Daisuke Kuzume, Shun Shimohama, Takayoshi Shimohata, Koji Abe, Tomohiko Ishihara, Osamu Onodera, Sagiri Isose, Nobuyuki Araki, Mitsuya Morita, Kazuyuki Noda, Tatsushi Toda, Hirofumi Maruyama, Hirokazu Furuya, Satoshi Teramukai, Tatsuo Kagimura, Kensuke Noma, Hiroaki Yanagawa, Satoshi Kuwabara, Ryuji Kaji, Yusuke Osaki, Hiroki Yamazaki, Shotaro Haji, Yumi Ishida, Akari Futami, Toshiko Miyamoto, Akiyo Akaishi, Kenshi Takechi, Kazuki Maeda, Shoko Kurisu, Mari Yoshizawa, Nozomu Matsuda, Tomoko Nakazato, Ryoichi Nakamura, Naoki Hayashi, Akihiro Kawata, Hideki Kimura, Kota Bokuda, Akiko Tamura, Chiho Ishida, Michi Kawamoto, Hyo Kim, Jun Kawamata, Shin Hisahara, Yuichi Kimura, Toru Yamashita, Yasuyuki Ohta, Kimihito Arai, Takahiro Takeda, Tomoo Ogawa, Shingo Ikari, Yasunori Ono & Yukio Fujino. (2022) Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis. JAMA Neurology 79:6, pages 575.
Crossref
Crossref
Paolo Tornese, Stefania Lalli, Antoniangela Cocco & Alberto Albanese. (2022) Review of disease-modifying drug trials in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 93:5, pages 521-529.
Crossref
Crossref
Aline Alves de Souza, Stephano Tomaz da Silva, Karen de Medeiros Pondofe, Vanessa Regiane Resqueti, Luciana Protásio de Melo, Ricardo Alexsandro de Medeiros Valentim & Tatiana Souza Ribeiro. (2022) Remote versus face-to-face home-based exercise programme in people with amyotrophic lateral sclerosis: protocol for a randomised clinical trial. BMJ Open 12:5, pages e056323.
Crossref
Crossref
Hussein Ali El-Khechen, Mohammed Inam Ullah Khan, Selvin Leenus, Oluwatobi Olaiya, Zoha Durrani, Zaryan Masood, Alvin Leenus, Shakib Akhter & Lawrence Mbuagbaw. (2021) Design, analysis, and reporting of pilot studies in HIV: a systematic review and methodological study. Pilot and Feasibility Studies 7:1.
Crossref
Crossref
Sergio Castro-Gomez, Barbara Radermacher, Pawel Tacik, Sandra R Mirandola, Michael T Heneka & Patrick Weydt. (2021) Teaching an old dog new tricks: serum troponin T as a biomarker in amyotrophic lateral sclerosis. Brain Communications 3:4.
Crossref
Crossref
Charis Wong, Maria Stavrou, Elizabeth Elliott, Jenna M Gregory, Nigel Leigh, Ashwin A Pinto, Timothy L Williams, Jeremy Chataway, Robert Swingler, Mahesh K B Parmar, Nigel Stallard, Christopher J Weir, Richard A Parker, Amina Chaouch, Hisham Hamdalla, John Ealing, George Gorrie, Ian Morrison, Callum Duncan, Peter Connelly, Francisco Javier Carod-Artal, Richard Davenport, Pablo Garcia Reitboeck, Aleksandar Radunovic, Venkataramanan Srinivasan, Jenny Preston, Arpan R Mehta, Danielle Leighton, Stella Glasmacher, Emily Beswick, Jill Williamson, Amy Stenson, Christine Weaver, Judith Newton, Dawn Lyle, Rachel Dakin, Malcolm Macleod, Suvankar Pal & Siddharthan Chandran. (2021) Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective. Brain Communications 3:4.
Crossref
Crossref
Seong-il Oh, Jin-Sung Park, Jung-Joon Sung & Seung Hyun Kim. (2021) Clinical Scales Used in Motor Neuron Disease. Journal of the Korean Neurological Association 39:2 Suppl, pages 77-86.
Crossref
Crossref
Zaynab Shakkour, Hawraa Issa, Helene Ismail, Ohanes Ashekyan, Karl John Habashy, Leila Nasrallah, Hussam Jourdi, Eva Hamade, Stefania Mondello, Mirna Sabra, Kazem Zibara & Firas Kobeissy. (2021) Drug Repurposing: Promises of Edaravone Target Drug in Traumatic Brain Injury. Current Medicinal Chemistry 28:12, pages 2369-2391.
Crossref
Crossref
Juan Fernando Ortiz, Sawleha Arshi Khan, Amr Salem, Zayar Lin, Zafar Iqbal & Nusrat Jahan. (2020) Post-Marketing Experience of Edaravone in Amyotrophic Lateral Sclerosis: A Clinical Perspective and Comparison With the Clinical Trials of the Drug. Cureus.
Crossref
Crossref
Namita A. Goyal, James D. Berry, Anthony Windebank, Nathan P. Staff, Nicholas J. Maragakis, Leonard H. van den Berg, Angela Genge, Robert Miller, Robert H. Baloh, Ralph Kern, Yael Gothelf, Chaim Lebovits & Merit Cudkowicz. (2020) Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS. Muscle & Nerve 62:2, pages 156-166.
Crossref
Crossref
Michael Benatar, Lanyu ZhangLily WangVolkan Granit, Jeffrey Statland, Richard BarohnAndrea SwensonJohn RavitsCarlayne JacksonTed M. BurnsJaya TrivediErik P. Pioro, James Caress, Jonathan KatzJacob L. McCauley, Rosa RademakersAndrea MalaspinaLyle W. OstrowJoanne WuuSumaira Hussain, Anne Cooley, Yindi Li, Marielle Wallace, Julie Steele, Jessica P Hernandez, Jessica Medina, Maria Elena Paredes, Ashley Manso, Natalia Ravelo, Wendy Levy, Patrice Whitehead, Stephan Zuchner, Mamatha Pasnoor, Omar Jawdat, Duaa Jabari, Constantine Farmakidis, Melanie Glenn, Mazen M Dimachkie, Laura Herbelin, Hellen Tanui, Sherri Anderson, Michaela Walker, Tina Liu, Ayla McCally, Andrew Heim, Melissa Currence, Yolanda Harness, Jeri Sieren, Emilee Gibson, Gil Gutierrez, Danielle Bussey, Rose Previte, Pamella Kittrell, Amruta Joshi, Amy Conger, Debbie Hastings, Irys Caristo, Mozhdeh Marandi, Simon Carty, J Paul Taylor, Gang Wu, Evadnie Rampersaud, Rebecca Schule & Marka van Blitterswijk. (2020) Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS. Neurology 95:1.
Crossref
Crossref
Jin-Mo Park, Sun-Young Kim, Donghwi Park & Jin-Sung Park. (2019) Effect of edaravone therapy in Korean amyotrophic lateral sclerosis (ALS) patients. Neurological Sciences 41:1, pages 119-123.
Crossref
Crossref
S Fadilah Abdul Wahid, Zhe Kang Law, Nor Azimah Ismail & Nai Ming Lai. (2019) Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews 2019:12.
Crossref
Crossref
James D. BerryMerit E. CudkowiczAnthony J. WindebankNathan P. StaffMargaret OwegiKatherine NicholsonDiane McKenna-YasekYossef S. LevyNatalie AbramovHaggai KaspiMunish MehraRevital ArichaYael GothelfRobert H. Brown. (2019) NurOwn, phase 2, randomized, clinical trial in patients with ALS. Neurology 93:24.
Crossref
Crossref
Marlena Wosiski-KuhnMac RobinsonJane StrupePhonepasong ArounleutMatthew MartinJames CaressMichael CartwrightRobert BowserMerit CudkowiczCarl LangefeldGregory A. HawkinsCarol Milligan. (2019)
IL6 receptor
358
Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis
. Neurology Neuroimmunology & Neuroinflammation 6:6.
Crossref
Crossref
Leila Bond, Paulamy Ganguly, Nishad Khamankar, Nolan Mallet, Gloria Bowen, Braden Green & Cassie S. Mitchell. (2019) A Comprehensive Examination of Percutaneous Endoscopic Gastrostomy and Its Association with Amyotrophic Lateral Sclerosis Patient Outcomes. Brain Sciences 9:9, pages 223.
Crossref
Crossref
Jessica Mandrioli, Valeria Crippa, Cristina Cereda, Valentina Bonetto, Elisabetta Zucchi, Annalisa Gessani, Mauro Ceroni, Adriano Chio, Roberto D’Amico, Maria Rosaria Monsurrò, Nilo Riva, Mario Sabatelli, Vincenzo Silani, Isabella Laura Simone, Gianni Sorarù, Alessandro Provenzani, Vito Giuseppe D’Agostino, Serena Carra & Angelo Poletti. (2019) Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS). BMJ Open 9:5, pages e028486.
Crossref
Crossref
Elisabetta Zucchi, Marco Vinceti, Carlotta Malagoli, Nicola Fini, Annalisa Gessani, Antonio Fasano, Romana Rizzi, Elisabetta Sette, Stefano Cavazza, Alena Fiocchi, Sergio Buja, Tiziana Faccioli, Simone Storani & Jessica Mandrioli. (2019) High‐frequency motor rehabilitation in amyotrophic lateral sclerosis: a randomized clinical trial. Annals of Clinical and Translational Neurology 6:5, pages 893-901.
Crossref
Crossref
Alan M. Hoeper, David W. Barbara, James C. Watson, Juraj Sprung & Toby N. Weingarten. (2019) Amyotrophic lateral sclerosis and anesthesia: a case series and review of the literature. Journal of Anesthesia 33:2, pages 257-265.
Crossref
Crossref
Jeffrey M. Statland, Dan Moore, Yunxia Wang, Maureen Walsh, Tahseen Mozaffar, Lauren Elman, Sharon P. Nations, Hiroshi Mitsumoto, J. Americo Fernandes, David Saperstein, Ghazala Hayat, Laura Herbelin, Chafic Karam, Jonathan Katz, Heather M. Wilkins, Abdulbaki Agbas, Russell H. Swerdlow, Regina M. Santella, Mazen M. Dimachkie & Richard J. Barohn. (2018) Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial. Muscle & Nerve 59:2, pages 201-207.
Crossref
Crossref
Thomas Welton, Jerome J. Maller, R. Marc Lebel, Ek T. Tan, Dominic B. Rowe & Stuart M. Grieve. (2019) Diffusion kurtosis and quantitative susceptibility mapping MRI are sensitive to structural abnormalities in amyotrophic lateral sclerosis. NeuroImage: Clinical 24, pages 101953.
Crossref
Crossref
Maisha T. Robinson & Danny Estupinan. 2019. Neuropalliative Care. Neuropalliative Care
101
115
.
Alex G. Karanevich, Jeffrey M. Statland, Byron J. Gajewski & Jianghua He. (2018) Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression. BMC Medical Research Methodology 18:1.
Crossref
Crossref
Kaila L. Stipancic, Yana Yunusova, James D. Berry & Jordan R. Green. (2018) Minimally Detectable Change and Minimal Clinically Important Difference of a Decline in Sentence Intelligibility and Speaking Rate for Individuals With Amyotrophic Lateral Sclerosis. Journal of Speech, Language, and Hearing Research 61:11, pages 2757-2771.
Crossref
Crossref
Ki-Wook Oh, Min-Young Noh, Min-Soo Kwon, Hyun Young Kim, Seong-il Oh, Jinseok Park, Hee-Jin Kim, Chang-Seok Ki & Seung Hyun Kim. (2018) Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis. Annals of Neurology 84:3, pages 361-373.
Crossref
Crossref
Albert C Ludolph, Joachim Schuster, Johannes Dorst, Luc Dupuis, Jens Dreyhaupt, Jochen H Weishaupt, Jan Kassubek, Ulrike Weiland, Susanne Petri, Thomas Meyer, Julian Grosskreutz, Berthold Schrank, Matthias Boentert, Alexander Emmer, Andreas Hermann, Daniel Zeller, Johannes Prudlo, Andrea S Winkler, Torsten Grehl, Michael T Heneka, Siw Wollebæk Johannesen, Bettina Göricke, Andreas Funke, Dagmar Kettemann, Robert Meyer, Thomas Meyer, Torsten Grehl, Kai Gruhn, Peter Schwenkreis, Philipp Stude, Michael T Heneka, Delia Kurzwelly, Andreas Hermann, Alexander Storch, Nicole Richter, Tobias Frank, Bettina Göricke, Katharina Hein, Alexander Emmer, Frank Hanisch, Dagmar Hanke, Torsten Kraya, Andreas Posa, Martina Romanakova, Susanne Schilling, Susanne Abdulla, Sebastian Böselt, Dagmar Hanke, Claas Janssen, Imken Lange, Xenia Kobeleva, Sonja Körner, Katja Kollewe, Alma Osmanovic, Susanne Petri, Nicole Scharn, Klaus J Rath, Christiane Dahms, Julian Grosskreutz, Anne Gunkel, Bianka Heiling, Thomas Ringer, Uta Smesny, Sarah Baumeister, Achim Berthele, Sarah Bublitz, Andrea S Winkler, Esra Akova-Öztürk, Matthias Boentert, Bianca Stubbe-Dräger, Alexandra Rahmann, Charlotte Young, Peter Young, Dobri Baldaranov, Ulrich Bogdahn, Siw Wollebæk Johannesen, Andrei Khomenko, Wilhelm Schulte-Mattler, Christina Stadler, Susanne Husung, Johannes Prudlo, Simone Tesar, Nigar Dargah-Zaden, Christina Last, Eva Langer, Albert C Ludolph, Jochen H Weishaupt, Ulrike Weiland, Ann-Sophie Lauenstein, Eckard Lensch, Carolyn Mc Farlane, Heike Fischer-Brasse, Klara Orbán, Bertold Schrank, Sonja Schürger, Stephan Klebe, Peter Kraft, Thomas Musacchio, Carola Seiler & Daniel Zeller. (2018) Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial. The Lancet Neurology 17:8, pages 681-688.
Crossref
Crossref
Stephen R. Pfohl, Renaid B. Kim, Grant S. Coan & Cassie S. Mitchell. (2018) Unraveling the Complexity of Amyotrophic Lateral Sclerosis Survival Prediction. Frontiers in Neuroinformatics 12.
Crossref
Crossref
Nimish J. Thakore, Brittany R. Lapin & Erik P. Pioro. (2018) Trajectories of impairment in amyotrophic lateral sclerosis: Insights from the Pooled Resource Open-Access ALS Clinical Trials cohort. Muscle & Nerve 57:6, pages 937-945.
Crossref
Crossref
Antonio Sarmento, Andrea Aliverti, Layana Marques, Francesca Pennati, Mario Emílio Dourado-Júnior, Guilherme Fregonezi & Vanessa Resqueti. (2018) Multiparametric Analysis of Sniff Nasal Inspiratory Pressure Test in Middle Stage Amyotrophic Lateral Sclerosis. Frontiers in Neurology 9.
Crossref
Crossref
Michael BenatarJoanne WuuPeter M. AndersenNazem AtassiWilliam DavidMerit CudkowiczDavid Schoenfeld. (2018)
Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive
SOD1
ALS
. Neurology 90:7.
Crossref
Crossref
Said R Beydoun & Jeffrey Rosenfeld. (2018) Edaravone in Amyotrophic Lateral Sclerosis’Lessons from the Clinical Development Program and the Importance of a Strategic Clinical Trial Design. US Neurology 14:1, pages 47.
Crossref
Crossref
Hiroshi Mitsumoto. (2017) Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy. Journal of Neurology, Neurosurgery & Psychiatry 88:12, pages 1004-1005.
Crossref
Crossref
Koji Abe, Masashi Aoki, Shoji Tsuji, Yasuto Itoyama, Gen Sobue, Masanori Togo, Chikuma Hamada, Masahiko Tanaka, Makoto Akimoto, Kazue Nakamura, Fumihiro Takahashi, Kazuoki Kondo, Hiide Yoshino, Koji Abe, Masashi Aoki, Shoji Tsuji, Yasuto Itoyama, Gen Sobue, Masanori Togo, Chikuma Hamada, Hidenao Sasaki, Ichiro Yabe, Shizuki Doi, Hitoshi Warita, Takashi Imai, Hiroaki Ito, Mitsumasa Fukuchi, Etsuko Osumi, Manabu Wada, Imaharu Nakano, Mitsuya Morita, Katsuhisa Ogata, Yuichi Maruki, Kimiko Ito, Osamu Kano, Mineo Yamazaki, Yuji Takahashi, Hiroyuki Ishiura, Mieko Ogino, Ryoko Koike, Chiho Ishida, Tsuyoshi Uchiyama, Kouichi Mizoguchi, Tomokazu Obi, Hirohisa Watanabe, Naoki Atsuta, Ikuko Aiba, Akira Taniguchi, Hideyuki Sawada, Takanori Hazama, Harutoshi Fujimura, Hirofumi Kusaka, Takenobu Kunieda, Hitoshi Kikuchi, Hidenori Matsuo, Hidetsugu Ueyama, Kazutoshi Uekawa, Masahiko Tanaka, Makoto Akimoto, Masaki Ueda, Aiko Murakami, Rie Sumii, Takuya Kudou, Kazue Nakamura, Kazunori Morimoto, Takatomo Yoneoka, Manabu Hirai, Kouichi Sasaki, Hidetomo Terai, Tomoko Natori, Hiroshi Matsui, Kuniko Kotani, Kaori Yoshida, Tomohisa Iwasaki, Fumihiro Takahashi, Kazuoki Kondo & Hiide Yoshino. (2017) Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. The Lancet Neurology 16:7, pages 505-512.
Crossref
Crossref
Richard Robinson. (2017) FDA Approves Edaravone for ALS. Neurology Today 17:11, pages 1,30-32.
Crossref
Crossref
L. Jensen, J. B. Djurtoft, R. D. Bech, J. L. Nielsen, L. H. Jørgensen, H. D. Schrøder, U. Frandsen, P. Aagaard & L. G. Hvid. (2017) Influence of Resistance Training on Neuromuscular Function and Physical Capacity in ALS Patients. Journal of Neurodegenerative Diseases 2017, pages 1-8.
Crossref
Crossref
Kevin B. Boylan, Mark A. Ross & Eric J. Sorenson. 2017. Neurodegeneration. Neurodegeneration
137
160
.
Vincent Meininger, Angela Genge, Leonard H van den Berg, Wim Robberecht, Albert Ludolph, Adriano Chio, Seung H Kim, P Nigel Leigh, Matthew C Kiernan, Jeremy M Shefner, Claude Desnuelle, Karen E Morrison, Susanne Petri, Diane Boswell, Jane Temple, Rajat Mohindra, Matt Davies, Jonathan Bullman, Paul Rees, Arseniy Lavrov, Susanne Abdulla, Cathy Alsop, Francesca Barbieri, Stewart Bates, James D Berry, Stephan A Botez, Gaelle Bruneteau, Andrea Calvo, Rodrigo Refoios Camejo, William Camu, Deven Chauhan, Veronique Danel-Brunaud, Jerzy Daniluk, Annelot Dekker, Alain Destee, Matthew Devine, Stephen DeWall, Johannes Dorst, Giuseppe Fuda, Harutoshi Fujimura, Andreas Funke, Torsten Grehl, Julian Grosskreutz, Usha Gungabissoon, Robert Henderson, Peggy Ho, William Huynh, Saiju Jacob, Raul Juntas-Morales, Byung-Jo Kim, Xenia Kobeleva, Sonja Koerner, Stephen Kolb, Katja Kollewe, Lawrence Korngut, Geraldine Lautrette, Amy Lee, Anthony Lynch, Rami Massie, Genevieve Matte, Darryl Menezes, Stefano Milleri, Linda Nichols, Kazutoshi Nishiyama, Mieko Ogino, Chris Parkinson, Pierre-François Pradat, Tino Prell, Jeffrey Price, Eleanor Ramsey, Thomas M Ringer, Kristiana Salmon, Christen Shoesmith, Marie Helene Soriani, Marloes Stam, Erik Steinberg, Rob Stubbs, Herman Sullivan, Philip Van Damme, Michael van Es, Anne Visser, Mary Lou Watson, Andrea Sylvia Winkler, Lorne Zinman & Margie Zoing. (2017) Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Neurology 16:3, pages 208-216.
Crossref
Crossref
Yeou-Jiunn Chen, Shih-Chung Chen, Ilham Zaeni & Chung-Min Wu. (2016) Fuzzy Tracking and Control Algorithm for an SSVEP-Based BCI System. Applied Sciences 6:10, pages 270.
Crossref
Crossref
Jessica Mandrioli, Sara Biguzzi, Carlo Guidi, Elisabetta Sette, Emilio Terlizzi, Alessandro Ravasio, Mario Casmiro, Fabrizio Salvi, Rocco Liguori, Romana Rizzi, Vladimiro Pietrini, Annamaria Borghi, Rita Rinaldi, Nicola Fini, Elisabetta Chierici, Mario Santangelo, Enrico Granieri, Vittoria Mussuto, Silvia De Pasqua, Eleni Georgoulopoulou, Antonio Fasano, Salvatore Ferro & Roberto D’Alessandro. (2015) Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy. Neurological Sciences 36:12, pages 2243-2252.
Crossref
Crossref
Christoph Neuwirth, Paul E Barkhaus, Christian Burkhardt, José Castro, David Czell, Mamede de Carvalho, Sanjeev Nandedkar, Erik Stålberg & Markus Weber. (2015) Tracking motor neuron loss in a set of six muscles in amyotrophic lateral sclerosis using the Motor Unit Number Index (MUNIX): a 15-month longitudinal multicentre trial. Journal of Neurology, Neurosurgery & Psychiatry 86:11, pages 1172-1179.
Crossref
Crossref
Neta Zach, David L. Ennist, Albert A. Taylor, Hagit Alon, Alexander Sherman, Robert Kueffner, Jason Walker, Ervin Sinani, Igor Katsovskiy, Merit Cudkowicz & Melanie L. Leitner. (2015) Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?. Neurotherapeutics 12:2, pages 417-423.
Crossref
Crossref
Merit Cudkowicz, Michael E Bozik, Evan W Ingersoll, Robert Miller, Hiroshi Mitsumoto, Jeremy Shefner, Dan H Moore, David Schoenfeld, James L Mather, Donald Archibald, Mary Sullivan, Craig Amburgey, Juliet Moritz & Valentin K Gribkoff. (2011) The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis. Nature Medicine 17:12, pages 1652-1656.
Crossref
Crossref
Paul Wicks, Timothy E Vaughan, Michael P Massagli & James Heywood. (2011) Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm. Nature Biotechnology 29:5, pages 411-414.
Crossref
Crossref